| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 1,400,000 | $2,926,000 | $2.09 | 19 Sep 2025 | Direct |
| CITIUS ONCOLOGY, INC. | Chief Financial Officer | Common Stock | 825,000 | $998,250 | $1.21 | 19 Sep 2025 | Direct |
| Citius Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 60,353 | $45,265 | $0.7500 | 07 Nov 2024 | Direct |
| Citius Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Purchase Common Stock) | 350,000 | 07 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Chief Financial Officer | 22 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Chief Financial Officer | 01 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Dec 2024 | 1 | $0 | 4 | Chief Financial Officer | 16 Dec 2024, 16:06 |
| CTXR | Citius Pharmaceuticals, Inc. | 07 Nov 2024 | 1 | $0 | 4 | Chief Financial Officer | 12 Nov 2024, 17:00 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Aug 2024 | 1 | $0 | 4/A | Chief Financial Officer | 30 Aug 2024, 16:05 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Aug 2024 | 0 | $0 | 3 | Chief Financial Officer | 14 Aug 2024, 18:20 |
| CTXR | Citius Pharmaceuticals, Inc. | 10 Oct 2023 | 1 | $0 | 4 | Chief Financial Officer | 12 Oct 2023, 16:15 |
| CTXR | Citius Pharmaceuticals, Inc. | 04 Oct 2022 | 1 | $0 | 4 | Chief Financial Officer | 06 Oct 2022, 16:07 |
| CTXR | Citius Pharmaceuticals, Inc. | 11 Oct 2021 | 1 | $0 | 4 | Chief Financial Officer | 13 Oct 2021, 17:25 |
| CTXR | Citius Pharmaceuticals, Inc. | 22 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 26 Jul 2021, 17:01 |